BioWorld

March 16, 2004

View Archived Issues

Gilead Seeking Approval For New Combination AIDS Pill

Gilead Sciences Inc. is requesting FDA approval of a co-formulation combining Viread with Emtriva in a single pill dosed once daily to be taken with other antiretrovirals for the treatment of HIV. (BioWorld Today) Read More

CoTherix IPO Seeking $70M To Fund Hypertension Drug

Read More

ChemoCentryx, Forest Form Partnership On Chemokines

Read More

CancerVax In-Licenses T-Oligos Platform To Oncology Pipeline

Read More

Other News To Note

Read More

U.S. Patent Disclosures

Read More